Phase Ib Clinical Trial of OPB-111077 in Patients With Relapsed or Refractory Acute Myeloid Leukaemia
Phase of Trial: Phase I
Latest Information Update: 13 Oct 2017
At a glance
- Drugs OPB 111077 (Primary)
- Indications Acute myeloid leukaemia
- Focus Adverse reactions
- 05 Oct 2017 Status changed from not yet recruiting to recruiting.
- 09 Aug 2017 Planned initiation date changed from 1 Jun 2017 to 1 Sep 2017.
- 27 Jun 2017 New trial record